- Home
- CYD vs GHRS Comparison
CYD vs GHRS Comparison
Compare CYD & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYD
- GHRS
- Stock Information
- Founded
- CYD 1951
- GHRS 2018
- Country
- CYD Singapore
- GHRS Ireland
- Employees
- CYD N/A
- GHRS N/A
- Industry
- CYD Industrial Machinery/Components
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- CYD Industrials
- GHRS Health Care
- Exchange
- CYD Nasdaq
- GHRS Nasdaq
- Market Cap
- CYD 379.3M
- GHRS 462.0M
- IPO Year
- CYD 1994
- GHRS 2021
- Fundamental
- Price
- CYD $11.92
- GHRS $8.99
- Analyst Decision
- CYD
- GHRS Strong Buy
- Analyst Count
- CYD 0
- GHRS 3
- Target Price
- CYD N/A
- GHRS $35.67
- AVG Volume (30 Days)
- CYD 86.4K
- GHRS 89.4K
- Earning Date
- CYD 02-25-2025
- GHRS 02-27-2025
- Dividend Yield
- CYD 3.23%
- GHRS N/A
- EPS Growth
- CYD 14.53
- GHRS N/A
- EPS
- CYD 1.17
- GHRS N/A
- Revenue
- CYD $2,639,608,357.00
- GHRS N/A
- Revenue This Year
- CYD $11.68
- GHRS N/A
- Revenue Next Year
- CYD $4.06
- GHRS N/A
- P/E Ratio
- CYD $8.87
- GHRS N/A
- Revenue Growth
- CYD 15.32
- GHRS N/A
- 52 Week Low
- CYD $7.95
- GHRS $5.92
- 52 Week High
- CYD $13.05
- GHRS $14.99
- Technical
- Relative Strength Index (RSI)
- CYD 68.91
- GHRS 58.18
- Support Level
- CYD $9.90
- GHRS $8.02
- Resistance Level
- CYD $10.68
- GHRS $10.23
- Average True Range (ATR)
- CYD 0.67
- GHRS 0.90
- MACD
- CYD 0.13
- GHRS 0.11
- Stochastic Oscillator
- CYD 90.42
- GHRS 62.20
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.